ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Imaging"

  • Abstract Number: 2637 • ACR Convergence 2025

    Initial Phospholipid Transferase Activity Is Predictive of Five-Year Sacroiliac Radiographic Progression in Axial Spondyloarthritis: Findings From the DESIR Cohort

    Frank Verhoeven1, Olivier Fakih1, Sophie Hecquet2, anne tournadre3, jean Paul Pais de Barros4, Céline Delougeot5, Clément Prati1 and WENDLING Daniel1, 1CHU de Besançon, Besançon, Franche-Comte, France, 2Rheumatology department, Cochin hospital, Paris, France, 3CHU Clermont ferrand, Clermont-Ferrand, France, 4Labex lipstick, Dijon, France, 5université Marie et Louis Pasteur, Besancon

    Background/Purpose: The pathophysiology of axial spondyloarthritis (axSpA) involves the gut-joint axis. Recent studies suggest more active disease in cases of gut involvement.The objective of this…
  • Abstract Number: 2145 • ACR Convergence 2025

    EOS® Imaging System Is a Novel, Rapid, Safe, and Effective Technique To Detect And Assess Calcinosis In JDM

    Jessica Perfetto1, Ciara Maguire2, Carli Needle3, Shailee Lala4, Vikash Oza2 and Philip Kahn5, 1Pediatric Rheumatology, Hassenfeld Children's Hospital at NYU Langone, New York, 2Pediatric Dermatology, Ronald O Perelman Department of Dermatology, NYU Grossman School of Medicine, New York, 3NYU Grossman School of Medicine, New York, 4Department of Radiology, NYU Grossman School of Medicine, New York, 5Pediatric Rheumatology, Hassenfeld Children’s Hospital at NYU Langone, New York

    Background/Purpose: Calcinosis, reported in up to 47% of children with juvenile dermatomyositis (JDM), can cause significant morbidity, including ulceration, infection, and contractures. Given associations of…
  • Abstract Number: 1952 • ACR Convergence 2025

    Dermatoscopy Limitation and the Critical Role of Capillaroscopy in Systemic Sclerosis and Raynaud’s Phenomenon among African American Veterans

    Genessis Maldonado1, Maurizio Cutolo2, Tracy Frech1, Mislav Radic3, Marcus Snow4 and Vanessa Smith5, 1Vanderbilt University Medical Center, Nashville, TN, 2University of Genova, Genova, Italy, 3University Hospital Split, Division of Rheumatology and Clinical Immunology, Split, Croatia, Split, Croatia, 4University of Nebraska Medical Center, Omaha, NE, 5Ghent University Hospital, Gent, Belgium

    Background/Purpose: Nailfold capillaroscopy (NFC) is an essential tool for evaluating microvascular abnormalities in patients with Raynaud’s phenomenon (RP) in United States (U.S.) Veterans (1). While…
  • Abstract Number: 1713 • ACR Convergence 2025

    Diagnostic Delay in Psoriatic Arthritis and its Impact on Radiological Outcomes: A Systematic Review and Meta-analysis of 23,894 Patients

    Mohamed Abdelsalam1, Menat Alla Ayman Ali Mahdy2, Maryam Lasheen3, Hadeer Hafez4, Nourhan Abouelella5, Abdelhfeez Moshrif6 and Mohamed Reda Awad7, 1Misr University For Science and Technology, 6 october, Al Jizah, Egypt, 2Misr University For Science and Technology, Nasr City, Al Qahirah, Egypt, 3Misr University For Science and Technology, Helwan, Al Qahirah, Egypt, 46th October University, 6 october, Al Jizah, Egypt, 5Faculty of Medicine, Misr University for Science and Technology, 6 october, Al Jizah, Egypt, 6Al Azhar University, Asyut, Egypt, assyut, Asyut, Egypt, 7Al Azhar University, Cairo, Egypt, Giza, Al Jizah, Egypt

    Background/Purpose: Psoriatic arthritis (PsA) remains widely underdiagnosed and misdiagnosed worldwide, leading to delays in appropriate management and increased disease burden. While diagnostic delay has been…
  • Abstract Number: 1304 • ACR Convergence 2025

    The role of PET/CT in evaluating rheumatologic conditions in children with fever of unknown origin – a multicenter study

    Neta Berlak1, Lydia Christodoulou2, Gil Amarilyo3, Oded Scheuerman4, Irit Tirosh5, Eyal Kristal6, Ester Forer7, Amit Carmi8, Alon Kalter9 and Yoel Levinsky10, 1Schneider children's medical center of Israel, Tel Aviv, Israel, 2Tel Hashomer, Periatric rheumatology unit, Tel Aviv, Israel, 3Schneider Children's Medical Center of Israel, Kibbutz Maggal, Israel, 4schneider children's meidcal center of Israel, Petah tikva, Israel, 5Tel Aviv universty, Ramat Gan, Israel, 6Soroka medical center Beer Sheva, Beer Sheva, Israel, 7Soroka medical center, Beer Sheva, Israel, 8Schneider children's meidcal center of Israel, Tel Aviv, Israel, 9Schneider children's medical center of ISrael, Petah Tikva, Israel, 10Schneider Children's Medical Cenetr of Israel, Tel Aviv University, JERUSALEM, Israel

    Background/Purpose: Fever of Unknown Origin (FUO) is a relatively common clinical challenge that is frequently referred for evaluation by pediatric rheumatologists. In many cases, it…
  • Abstract Number: 0880 • ACR Convergence 2025

    Detecting Interstitial Lung Disease and Identifying Extensive Disease on Chest Computed Tomography in Patients with Systemic Sclerosis: Cut-Offs for Lung Texture Analysis and its Prognostic Implications

    Nicholas landini1, lisa Jungblut2, cecilia strappa3, Christian Blüthgen2, Rucsandra Dobrota4, Muriel Elhai5, Carina Mihai6, Sinziana Muraru-Carbune2, Martina Orlandi7, mariaelena Occhipinti8, Khadija El-Aoufy9, Gemma Lepri10, valeria panebianco11, anna rita larici3, Anna-Maria Hoffmann-Vold12, Cosimo Nardi13, Serena Guiducci14, Silvia Bellando-Randone15, Marco Matucci-Cerinic16, Thomas Frauenfelder2, Oliver Distler17 and Cosimo Bruni18, 1Department of Radiological Sciences, Oncology and Pathology, "Sapienza" University, Policlinico Umberto I, Rome, Italy. Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland, Rueil Malmaison, France, 2Institute for Diagnostic and Interventional Radiology, University Hospital Zurich, University Zurich, Zurich, Switzerland, zurich, Switzerland, 3Advanced Radiology Center, Department of Diagnostic Imaging and Oncological Radiotherapy, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Rome, Italy, rome, Italy, 4Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich, University of Zurich, the LOOP Zurich, Zurich, Switzerland, 5Institute for Diagnostic and Interventional Radiology, University Hospital Zurich, University Zurich, Zurich, Switzerland, Schlieren, Switzerland, 6University Hospital Zurich, University of Zurich, Zurich, Switzerland, 7Rheumatology Unit, Department of Medical and Surgical Sciences for Children and Adults, University Hospital of Modena and Reggio Emilia School of Medicine, Italy., modena, Italy, 8Division of Radiology, Fondazione Toscana Gabriele Monasterio, Pisa, Italy., pisa, Italy, 9Department of Health Science, University of Florence, Florence, Italy., firenze, Italy, 10Department of Experimental and Clinical Medicine, University of Florence, Division of Rheumatology Scleroderma Unit, AOU Careggi Hospital, Florence, Italy., Florence, Italy, 11Department of Radiological Sciences, Oncology and Pathology, "Sapienza" University, Policlinico Umberto I, Rome, Italy., Rome, Italy, 12Oslo University Hospital, Oslo, Norway, 13Department of Experimental and Clinical Biomedical Sciences, Radiodiagnostic Unit n. 2, University of Florence - Azienda Ospedaliero-Universitaria Careggi, Florence, Italy, Florence, Italy, 14Department of Experimental and Clinical Medicine, Scleroderma Unit, Division of Rheumatology, University of Florence, Azienda Ospedaliera Universitaria Careggi, Florence, Italy, Pistoia, Italy, 15University of Florence, Florence, Florence, Italy, 16University San Raffaele Milano, Milano, Milan, Italy, 17Department of Rheumatology, University Hospital Zurich, University of Zurich, Switzerland, Zurich, Switzerland, 18University of Zurich, Zurich, Switzerland

    Background/Purpose: Interstitial lung disease (ILD) is a leading cause of death in patients with systemic sclerosis (SSc), especially in case of extensive disease detected on…
  • Abstract Number: 0249 • ACR Convergence 2025

    Obesity as a possible confusion factor in the scleroderma pattern

    Eva Álvarez Andrés1, Marta Novella-Navarro2, Paloma García de la Peña Lefebvre3, Eugenio de Miguel2 and Paz Collado Ramos4, 1Hospital Severo Ochoa de Madrid, Madrid, Spain, 2Hospital Universitario La Paz, Madrid, Spain, 3Facultad ciencias de la Salud HM de la UCJC, Madrid, Spain, 4Department of Rheumatology, Hospital Universitario Severo Ochoa, Madrid, Spain,, MADRID, Madrid, Spain

    Background/Purpose: The 2023 EULAR criteria for systemic sclerosis reaffirm the diagnostic value of nailfold videocapillaroscopy (NVC), particularly the presence of giant capillaries and capillary loss…
  • Abstract Number: 2635 • ACR Convergence 2025

    Differences in structural lesions of the spine between patients with early axSpA and non-axSpA chronic back pain: 2-year results of the SPACE Cohort

    Gizem Ayan1, Liese de Bruin2, Miranda van Lunteren2, Manouk de Hooge3, Ana Bento da Silva2, Mary Lucy Marques4, Monique Reijnierse5, Victoria Navarro-Compan6, Marleen van de sande7, Inger Jorid Berg8, Roberta Ramonda9, Sofia Exarchou10, Désirée Van Der Heijde2, Floris A. van Gaalen2 and Sofia Ramiro11, 1Ankara Research and Training Hospital, Ankara, Turkey, 2Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 3Department of Rheumatology, Ghent University Hospital, Ghent, Belgium, 4Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands; and Coimbra Local Health Unit, Coimbra, Portugal, 5Department of Radiology, Leiden University Medical Center, Leiden, Netherlands, 6Department of Rheumatology, La Paz University Hospital, IdiPaz, Madrid, Spain, 7The Department of Rheumatology and Clinical Immunology, Amsterdam University Medical Center, Amsterdam, Netherlands, 8Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway, 9Rheumatology Unit-DIMED-University of Padova ITALY, Padova, Padua, Italy, 10Lund University, Åkarp, Skane Lan, Sweden, 11Leiden University Medical Center, Bunde, Netherlands

    Background/Purpose: The difference in spinal structural lesions and their progression over time between chronic back pain (CBP) patients with and without early axSpA is unknown.…
  • Abstract Number: 2106 • ACR Convergence 2025

    Prevalence and Characteristics of Morphometric Vertebral Fractures in the Spanish Population: Data from the OsteoSER Study

    Carmen Gomez Vaquero1, Montserrat Roig Kim2, Jordi Fiter Areste3, Marta Domínguez-Álvaro4, Luis María Jiménez Liñán5, Miguel Bernad6, Antonio Álvarez-Cienfuegos7, Blanca Correa8, Antonio Pascual-Vergara9, Alejandra Montero Costa10, Cristina Momblan Trejo11, Manuel Jiménez Rodríguez12, María Anadón González13, Sara Josefina Barcat Zarate14, Sara Alvar Pariente15, Cristina Ruiz Pavón16, Pedro J. Lacalle Chanivet17, Balbina Marín de Prada18, Soledad García Frías19, Francisco Javier Maestro Saavedra20, Marta Poch i Mora21, José Luis Gea González22, Carlota Quiroga Fernández23, Eduardo Acevedo Martel24 and Enrique González-Dávila25, 1Hospital Universitari de Bellvitge, 08907 L'Hospitalet, Spain, 2Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain, 3Hospital Universitari Son Espases, Palma de Mallorca, Spain, 4Sociedad Española de Reumatología, Madrid, Spain, 5Hospital Don Benito-Villanueva, Don Benito, Spain, 6Hospital Universitario La Paz, Madrid, Spain, 7Hospital Vega Baja, Orihuela, Spain, 8Clínica Sanz y Correa, A Coruña, Spain, 9Centro de Salud Ronda-Norte y Ronda-Sur, Ronda, Spain, 10Centro de Salud Fuencarral, Madrid, Spain, 11Centro de Atención Primaria Viladecans Montbaig, Sant Climent de Llobregat, Spain, 12Centro de Salud Don Benito Oeste, Don Benito, Spain, 13Consultorio de Pedrezuela, Pedrezuela, Spain, 14Centro de Salud Orihuela 1-El Rabaloche, Orihuela, Spain, 15Centro de Salud Malpica, Malpica, Spain, 16Centro de Salud Ronda-Norte, Ronda, Spain, 17Centro de Salud de Santa Amalia, Santa Amalia, Spain, 18Centro de Atención Primaria Ramona Via i Pros, El Prat de Llobregat, Spain, 19Centro de Salud de Cortes de la Frontera, Cortes de la Frontera, Spain, 20Centro de Salud Elviña Mesoiro, A Coruña, Spain, 21Centro de Atención Primaria CAP 17 de Setembre, El Prat de Llobregat, Spain, 22Centro de Salud de Benejúzar, Benezujar, Spain, 23Centro de Salud Os Mallos, A Coruña, Spain, 24Centro de Salud Ronda-Sur Santa Bárbara, Ronda, Spain, 25Departamento de Matemáticas. Universidad de La Laguna, Tenerife, Spain

    Background/Purpose: Most vertebral fractures (VFs) are asymptomatic. Vertebral Fracture Assessment (VFA) using DXA is a low-radiation method to detect morphometric vertebral fractures (MVFs). This study…
  • Abstract Number: 1953 • ACR Convergence 2025

    Machine Learning-Based Classification of Raynaud’s Phenomenon and Autoimmune Diseases in Indeterminate Capillaroscopic Patterns

    Genessis Maldonado1, Adela Marin Ballve2, Luis Sáez Comet3, Mayka Freire Dapena4, Miguel Antonio Mesa5, Miguel Martín Cascón6, Gema María Lledó Ibáñez7, Elena Martínez Robles8, Begoña Marí-Alfonso9, Alfredo Guillén del Castillo10, Carmen Pilar Simeón Aznar10, Borja del Carmelo Gracia Tello2, Eduardo Ramos ibáñez11 and Tracy Frech12, 1Vanderbilt University Medical Center, Nashville, 2Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain, 3Hospital Universitario Miguel Servet; Zaragoza, Zaragoza, Spain, 4Hospital Clínico Universitario de Santiago de Compostela, La Coruña, Spain, 5Universidad Pontificia Bolivariana, Medellin, Colombia, 6Hospital General Universitario Morales Meseguer, Murcia, Spain, 7Hospital Clínic de Barcelona, Barcelona, Spain, 8Hospital Universitario La Paz, Madrid, Spain, 9Hospital Universitario Parc Taulí, Barcelona, Spain, 10Hospital Universitario Vall D´Hebron, Barcelona, Spain, 11Capillary.io, Zaragoza, Aragon, Spain, 12Vanderbilt University Medical Center, Nashville, TN

    Background/Purpose: Artificial intelligence (AI) has increasingly been integrated into the analysis of nailfold capillaroscopy (NFC), offering new opportunities to automate image interpretation and enhance diagnostic…
  • Abstract Number: 1710 • ACR Convergence 2025

    Defining sonographic enthesitis in psoriatic arthritis: Developing a data- and expert-driven definition for inflammatory enthesitis at the single enthesis level

    Andre Lucas Ribeiro1, Sibel Aydin2, Gurjit Kaeley3, Fahmeen J. Afgani4, Catherine Bakewell5, Marcos Rosemffet6, Minna Kohler7, Amir Haddad8, Maria S. Stoenoiu9, Ari Polachek10, josefina marin11, Arnon Katz12, Sahil Koppikar13 and Lihi Eder14, 1Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil, 2Department of Medicine, University of Ottawa, The Ottawa Hospital Research Institute, Ottawa, ON, Canada, 3UF COM-J, Ponte Vedra Beach, FL, 4Women's College Hospital, Toronto, Canada, 5Intermountain Healthcare, Salt Lake City, UT, 6Instituto de Rehabilitación Psicofísica, Capital Federal, Argentina, 7Massachusetts General Hospital, Harvard Medical School, Boston, MA, 8Carmel Medical Centre, Haifa, Israel, 9Cliniques Universitaires Saint-Luc, Brussels, Belgium, 10Rheumatology Institute of Beilinson Hospital, Petah Tikva, Israel, 11Hospital Universitario Rey Juan Carlos, Madrid, Spain, 12GRAPPA, Seattle, 13Women's College Hospital & University of Toronto, Markham, ON, Canada, 14University of Toronto, Toronto, ON, Canada

    Background/Purpose: Enthesitis affects 30–40% of PsA patients but remains difficult to diagnose due to overlap with non-specific entheseal pain. While OMERACT has standardized ultrasound (US)…
  • Abstract Number: 1239 • ACR Convergence 2025

    JAK inhibition appears to alter clinical and neurobiological markers of nociplastic pain in rheumatoid arthritis: a 7T MRI Brain study

    Kristian Stefanov1, Andrew McGucken1, Maxine Arnott1, Tyrone Lau1, Norah Aldehmi1, Vinod Kumar2, Neil McKay3, James Dale4, Lindsay Robertson5, James Brock1, Flavia Sunzini6 and Neil Basu7, 1University of Glasgow, Glasgow, United Kingdom, 2NHS Tayside, Dundee, United Kingdom, 3NHS Lothian, Edinburgh, United Kingdom, 4NHS Lanarkshire, Wishaw, United Kingdom, 5NHS Grampian, Aberdeen, United Kingdom, 6Glasgow University, Glasgow, United Kingdom, 7Institute of Infection, Immunity & Inflammation, University of Glasgow, Glasgow, United Kingdom

    Background/Purpose: Pain remains a prevalent and highly impactful issue for people with rheumatoid arthritis (RA). Among modern day targeted therapies, the janus kinase (JAK) inhibitors…
  • Abstract Number: 0878 • ACR Convergence 2025

    Effects of IL-17A Inhibition on Entheseal Osteoblast and Fibroblast Dynamics in Psoriatic Arthritis: Insights from the EBIO Biopsy Study

    Maria Gabriella Raimondo1, Hashem Mohammadian2, Simon Rauber3, Stefano Alivernini4, Filippo Fagni5, Giulia Corte6, Koray Tascilar7, Alina Mihaela Ramming8, Juergen Rech2, Maria Antonietta D´Agostino9, Georg Schett2, Milena Pachowsky8, Arnd Kleyer10 and Andreas Ramming11, 1Department of Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg and Uniklinikum Erlangen, Erlangen, Germany, 2Uniklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany, Erlangen, Germany, 3Uniklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany, Erlangen, Bayern, Germany, 4Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy, 5Department of Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-Universität Erlangen-Nürnberg and University Hospital Erlangen, Erlangen, Bayern, Germany, 6- Department of Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-Universität Erlangen-Nürnberg and Uniklinikum Erlangen, Erlangen, Germany, Erlangen, Germany, 7Department of Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-Universität Erlangen-Nürnberg and University Hospital Erlangen, Erlangen, Germany, 8Department of Internal Medicine 3 – Rheumatology and Immunology, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany, 94Division of Rheumatology - Fondazione Policlinico Universitario A. Gemelli IRCCS - Università Cattolica del Sacro Cuore, Rome, Italy, 10Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany, Berlin, Germany, 11Department of Internal Medicine 3, Rheumatology & Immunology, Friedrich-Alexander-University (FAU) & Universitätsklinikum Erlangen, Erlangen, Germany

    Background/Purpose: Enthesitis is an early event in the course of psoriatic arthritis (PsA) and a hallmark feature of the disease. Currently, much of the understanding…
  • Abstract Number: 0242 • ACR Convergence 2025

    Contemporary Recurrent Pericarditis Management – Real-world Evidence of Limited Cardiac Magnetic Resonance Imaging Prior to Initiating Rilonacept

    Brittany Weber1, Paul Cremer2, Michael Garshick3, Sushil Allen Luis4, Ajit Raisinghani5, Vidhya Parameswaran6, Allison Curtis6, Allan Klein7 and John Paolini6, 1Brigham and Women's Hospital, DEDHAM, MA, 2Cleveland Clinic, Shaker Heights, OH, 3NYU Langone Health, Tenafly, NJ, 4Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, 5Division of Cardiology, Department of Medicine, Sulpizio Cardiovascular Center, University of California San Diego, San Diego, CA, 6Kiniksa Pharmaceuticals, LEXINGTON, MA, 7Cleveland Clinic, Cleveland, OH

    Background/Purpose: Recurrent pericarditis (RP) is a chronic autoinflammatory disease (mediated by IL-1) that requires long-term treatment, and selection of therapy is guided by multiple factors.…
  • Abstract Number: 2613 • ACR Convergence 2025

    Ga-FAPI-04 PET/CT reveals increased fibroblast activation in synovial and enthesial tissues of psoriasis patients with arthralgia and predicts the development of psoriatic arthritis

    Giulia Corte1, Koray Tascilar2, armin Atzinger3, Alp Temiz2, Melek Yalcin Mutlu4, Rita Noversa de Sousa5, Maria Gabriella Raimondo6, Andreas Ramming7, Sara Bayat2, Michael Sticherling8, Torsten Kuwert9, Christian Schmidkonz9, Georg Schett10 and Filippo Fagni11, 1- Department of Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-Universität Erlangen-Nürnberg and Uniklinikum Erlangen, Erlangen, Germany, Erlangen, Germany, 2Department of Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-Universität Erlangen-Nürnberg and University Hospital Erlangen, Erlangen, Germany, 3Department of Nuclear Medicine, Friedrich-Alexander University (FAU) Erlangen-Nuremberg and Universitätsklinikum Erlangen, Erlangen, Germany, Erlangen, Germany, 4Department of Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-Universität Erlangen-Nürnberg and Uniklinikum Erlangen, Erlangen, Germany, erlangen, 5Department of Internal Medicine 3, Friedrich-Alexander University (FAU) Erlangen-Nuremberg and Universitätsklinikum Erlangen, Erlangen, Germany, Erlangen, 6Department of Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg and Uniklinikum Erlangen, Erlangen, Germany, 7Department of Internal Medicine 3, Rheumatology & Immunology, Friedrich-Alexander-University (FAU) & Universitätsklinikum Erlangen, Erlangen, Germany, 8Department of Dermatology, Friedrich-Alexander University (FAU) Erlangen-Nuremberg and Universitätsklinikum Erlangen, Erlangen, Germany, Erlangen, Germany, 9Department of Nuclear Medicine, Friedrich-Alexander University (FAU) Erlangen-Nuremberg and Universitätsklinikum Erlangen, Erlangen, Germany, Erlangen, 10Uniklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany, Erlangen, Germany, 11Department of Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-Universität Erlangen-Nürnberg and University Hospital Erlangen, Erlangen, Bayern, Germany

    Background/Purpose: 68Ga-FAPI-04 PET/CT reveals fibroblast activation in vivo and is increasingly used to assess rheumatic diseases, including inflammatory arthritides. (1,2) We previously demonstrated that the…
  • 1
  • 2
  • 3
  • …
  • 43
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology